Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

152
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
152
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

195
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
195
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

186
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
186
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
139
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

190
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
190

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transitioning Adolescents and Young Adults With Neurogastroenterology and Motility Disorders to Adult Care. Current Practices and Challenges in North America.

Neurogastroenterology and motility·2026
Same author

Evaluating linaclotide for the treatment of irritable bowel syndrome with constipation in children and adolescents.

Expert opinion on pharmacotherapy·2026
Same author

Menstrual-Associated Gastrointestinal Symptoms and Their Impact on IBS Diagnosis in Adolescents.

Neurogastroenterology and motility·2026
Same author

CBT for Pediatric Functional Abdominal Pain: Time to Rethink Traditional Assumptions?

The American journal of gastroenterology·2026
Same author

Knowledge Does Not Translate Into Diagnostic Restraint: Application of Rome-Based IBS Diagnosis Among Medical Students in Latin America.

Neurogastroenterology and motility·2026
Same author

Evaluating linaclotide for the treatment of functional constipation in children and adolescents.

Expert opinion on pharmacotherapy·2026

相关实验视频

Updated: Jun 20, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

381

最近在治疗儿童便秘方面取得的进展.

Sharon Wolfson1, Miguel Saps2

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Expert review of gastroenterology & hepatology
|July 22, 2024
PubMed
概括

针对儿科功能性便秘 (FC) 的新疗法正在出现,这是一个常见的疾病. 虽然林纳克洛提德现在已被FDA批准用于儿童,但对于个性化FC管理,进一步研究安全性和有效性至关重要.

科学领域:

  • 儿科胃肠病学 儿科胃肠病学
  • 药理学 药理学是指药理学的学科.
  • 手术干预 手术干预

背景情况:

  • 功能性便秘 (FC) 影响了大量儿童,大约30%的儿童对标准治疗没有反应.
  • 目前的管理往往涉及生活方式的改变和透性药,但新的治疗途径正在变得可用.

研究的目的:

  • 审查当前和新兴的药理学,手术和神经调节疗法用于儿科功能性便秘.
  • 讨论儿童这些不同治疗方式的疗效和安全数据.

主要方法:

  • 对儿科FC的现有和新型治疗方案的文献综述.
  • 来自临床研究和专家意见的疗效和安全数据的分析.

主要成果:

  • 第一个药理学药物,林纳克洛提德,在2023年获得FDA批准,用于治疗6-17岁儿童的FC.
  • 目前正在探索各种药理学,手术和神经调节方法,用于儿科FC管理.

结论:

  • 对儿童群体新型FC治疗的安全性和疗效进行进一步的研究至关重要.
  • 预计针对儿童FC管理的个性化方法,考虑到与成年人不同的病理生理学,可以改善结果.
关键词:
5HT-4激动剂的激动剂吸收者吸收者吸收者吸收者功能性便秘 功能性便秘神经刺激的神经刺激透性液剂 透性液剂 透性液剂儿科 儿科 儿科 儿科秘密的代理人 秘密的代理人兴奋剂 放松剂 放松剂

更多相关视频

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

1.8K
Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
08:24

Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models

Published on: August 11, 2023

2.1K

相关实验视频

Last Updated: Jun 20, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

381
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

1.8K
Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
08:24

Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models

Published on: August 11, 2023

2.1K